Celldex Therapeutics (CLDX) Leases (2019 - 2025)
Historic Leases for Celldex Therapeutics (CLDX) over the last 7 years, with Q3 2025 value amounting to $2.7 million.
- Celldex Therapeutics' Leases fell 1429.02% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 1429.02%. This contributed to the annual value of $3.9 million for FY2024, which is 5126.12% up from last year.
- Celldex Therapeutics' Leases amounted to $2.7 million in Q3 2025, which was down 1429.02% from $3.1 million recorded in Q2 2025.
- Celldex Therapeutics' 5-year Leases high stood at $4.0 million for Q4 2022, and its period low was $2.2 million during Q1 2024.
- Its 5-year average for Leases is $3.1 million, with a median of $3.1 million in 2021.
- Per our database at Business Quant, Celldex Therapeutics' Leases plummeted by 4040.74% in 2024 and then skyrocketed by 6230.95% in 2025.
- Celldex Therapeutics' Leases (Quarter) stood at $3.0 million in 2021, then skyrocketed by 34.71% to $4.0 million in 2022, then tumbled by 35.59% to $2.6 million in 2023, then surged by 51.26% to $3.9 million in 2024, then crashed by 30.3% to $2.7 million in 2025.
- Its last three reported values are $2.7 million in Q3 2025, $3.1 million for Q2 2025, and $3.5 million during Q1 2025.